<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Toxicol Sci</journal-id>
<journal-id journal-id-type="iso-abbrev">Toxicol. Sci</journal-id>
<journal-id journal-id-type="publisher-id">toxsci</journal-id>
<journal-id journal-id-type="hwp">toxsci</journal-id>
<journal-title-group>
<journal-title>Toxicological Sciences</journal-title>
</journal-title-group>
<issn pub-type="ppub">1096-6080</issn>
<issn pub-type="epub">1096-0929</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26919959</article-id>
<article-id pub-id-type="pmc">4880132</article-id>
<article-id pub-id-type="doi">10.1093/toxsci/kfw041</article-id>
<article-id pub-id-type="publisher-id">kfw041</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Identification of Cholesterol Biosynthesis Inhibitors</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Identification of Environmental Quaternary Ammonium Compounds as Direct Inhibitors of Cholesterol Biosynthesis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Herron</surname>
<given-names>Josi</given-names>
</name>
<xref ref-type="aff" rid="kfw041-aff1">*</xref>
<xref ref-type="aff" rid="kfw041-aff2">
<sup>†</sup>
</xref>
<xref ref-type="author-notes" rid="kfw041-FM3">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Reese</surname>
<given-names>Rosalyn C.</given-names>
</name>
<xref ref-type="aff" rid="kfw041-aff3">
<sup>‡</sup>
</xref>
<xref ref-type="author-notes" rid="kfw041-FM3">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="kfw041-FM1">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tallman</surname>
<given-names>Keri A.</given-names>
</name>
<xref ref-type="aff" rid="kfw041-aff3">
<sup>‡</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Narayanaswamy</surname>
<given-names>Rohini</given-names>
</name>
<xref ref-type="aff" rid="kfw041-aff3">
<sup>‡</sup>
</xref>
<xref ref-type="author-notes" rid="kfw041-FM2">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Porter</surname>
<given-names>Ned A.</given-names>
</name>
<xref ref-type="aff" rid="kfw041-aff3">
<sup>‡</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xu</surname>
<given-names>Libin</given-names>
</name>
<xref ref-type="aff" rid="kfw041-aff1">*</xref>
<xref ref-type="corresp" rid="kfw041-cor1">
<sup>4</sup>
</xref>
</contrib>
<aff id="kfw041-aff1">*Department of Medicinal Chemistry, University of Washington, Seattle, Washington;</aff>
<aff id="kfw041-aff2"><sup>†</sup>Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, Washington;</aff>
<aff id="kfw041-aff3"><sup>‡</sup>Department of Chemistry, Vanderbilt University, Nashville, Tennessee</aff>
</contrib-group>
<author-notes>
<fn id="kfw041-FM3">
<p><sup>1</sup>These authors contributed equally to the manuscript.</p>
</fn>
<fn id="kfw041-FM1">
<p><sup>2</sup>Present address: College of Pharmacy, University of Georgia, Athens, GA.</p>
</fn>
<fn id="kfw041-FM2">
<p><sup>3</sup>Present address: Agios Pharmaceuticals, Cambridge, MA.</p>
</fn>
<corresp id="kfw041-cor1"><sup>4</sup>To whom correspondence should be addressed. Fax: <fax>206-685-3252</fax>. E-mail: <email>libinxu@uw.edu</email>.</corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>6</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>26</day>
<month>2</month>
<year>2016</year>
</pub-date>
<volume>151</volume>
<issue>2</issue>
<fpage>261</fpage>
<lpage>270</lpage>
<permissions>
<copyright-statement>© The Author 2016. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com</copyright-statement>
<copyright-year>2016</copyright-year>
</permissions>
<abstract>
<p>In this study, we aim to identify environmental molecules that can inhibit cholesterol biosynthesis, potentially leading to the same biochemical defects as observed in cholesterol biosynthesis disorders, which are often characterized by congenital malformations and developmental delay. Using the Distributed Structure-Searchable Toxicity (DSSTox) Database Network developed by EPA, we first carried out <italic>in silico</italic> screening of environmental molecules that display structures similar to AY9944, a known potent inhibitor of 3β-hydroxysterol-Δ<sup>7</sup>-reductase (DHCR7)—the last step of cholesterol biosynthesis. Molecules that display high similarity to AY9944 were subjected to test in mouse and human neuroblastoma cells for their effectiveness in inhibiting cholesterol biosynthesis by analyzing cholesterol and its precursor using gas chromatography-mass spectrometry. We found that a common disinfectant mixture, benzalkonium chlorides (BACs), exhibits high potency in inhibiting DHCR7, as suggested by greatly elevated levels of the cholesterol precursor, 7-dehydrocholesterol (7-DHC). Subsequent structure-activity studies suggested that the potency of BACs as Dhcr7 inhibitors decrease with the length of their hydrocarbon chain: C10 &gt; C12 ≫ C14 &gt; C16. Real-time qPCR analysis revealed upregulation of the genes related to cholesterol biosynthesis and downregulation of the genes related to cholesterol efflux, suggesting a feedback response to the inhibition. Furthermore, an oxidative metabolite of 7-DHC that was previously identified as a biomarker <italic>in vivo</italic> was also found in cells exposed to BACs by liquid chromatography-mass spectrometry. Our findings suggest that certain environmental molecules could potently inhibit cholesterol biosynthesis, which could be a new link between environment and developmental disorders. </p>
</abstract>
<kwd-group kwd-group-type="author">
<kwd>benzalkonium chlorides</kwd>
<kwd>cholesterol biosynthesis inhibition</kwd>
<kwd>DHCR7</kwd>
<kwd>7-dehydrocholesterol</kwd>
<kwd>quaternary ammonium compounds.</kwd>
</kwd-group>
<counts>
<page-count count="10"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>